| RS2535392949 |
POR
|
Health Risk |
Pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS2535393241 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2535394735 |
POR
|
Health Risk |
Pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS2535394998 |
PMS2
|
Health Risk |
Likely pathogenic |
Lynch syndrome 4, Lynch syndrome 4 |
| RS2535395073 |
POR
|
Health Risk |
Pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS2535397538 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2535400917 |
POR
|
Health Risk |
Pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS2535401325 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2535401475 |
POR
|
Health Risk |
Pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS2535401580 |
POR
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS2535402021 |
POR
|
Health Risk |
Likely pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS2535403044 |
SAMD9L
|
Health Risk |
Likely pathogenic |
— |
| RS2535404377 |
POR
|
Health Risk |
Pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS2535407087 |
DDC
|
Health Risk |
Pathogenic |
Deficiency of aromatic-L-amino-acid decarboxylase, Deficiency of aromatic-L-amino-acid decarboxylase |
| RS2535408384 |
SAMD9L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2535408940 |
LAMB1
|
Health Risk |
Pathogenic |
— |
| RS2535408971 |
POR
|
Health Risk |
Pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS2535409791 |
POR
|
Health Risk |
Pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS2535411057 |
POR
|
Health Risk |
Pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS2535411225 |
POR
|
Health Risk |
Likely pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS2535412179 |
POR
|
Health Risk |
Likely pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS2535412257 |
POR
|
Health Risk |
Pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS2535412345 |
SAMD9L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2535412438 |
POR
|
Health Risk |
Pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS2535412896 |
SAMD9L
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-pancytopenia syndrome, Ataxia-pancytopenia syndrome |
| RS2535413569 |
POR
|
Health Risk |
Pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS2535414492 |
POR
|
Health Risk |
Pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS2535415169 |
POR
|
Health Risk |
Likely pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS2535421216 |
SAMD9L
|
Health Risk |
Likely pathogenic |
— |
| RS2535422664 |
SAMD9L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2535423064 |
SAMD9L
|
Health Risk |
Likely pathogenic |
SAMD9L-related disorder, SAMD9L-related disorder |
| RS2535424504 |
COL11A2
|
Health Risk |
Pathogenic |
— |
| RS2535428137 |
SAMD9L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2535434029 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2535434198 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2535438169 |
SAMD9L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2535439545 |
EGFR
|
Health Risk |
Pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS2535440714 |
EGFR
|
Health Risk |
Pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS2535448305 |
LAMB1
|
Health Risk |
Pathogenic |
— |
| RS2535448587 |
EGFR
|
Health Risk |
Pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS2535451617 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS2535454664 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS2535454681 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS2535454710 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS2535454764 |
SLC26A3
|
Health Risk |
Pathogenic |
Congenital secretory diarrhea, chloride type |
| RS2535456352 |
SLC26A3
|
Health Risk |
Pathogenic |
SLC26A3-related disorder, SLC26A3-related disorder |
| RS2535456378 |
SLC26A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS2535458383 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS2535458490 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS2535462703 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS2535462796 |
SLC26A3
|
Health Risk |
Likely pathogenic |
— |
| RS2535463162 |
SLC26A3
|
Health Risk |
Likely pathogenic |
— |
| RS2535463398 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS2535463519 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS2535463622 |
SLC26A3
|
Health Risk |
Likely pathogenic |
— |
| RS2535463696 |
DNAH11
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, DNAH11-related disorder |
| RS2535464064 |
DNAH11
|
Health Risk |
Pathogenic |
DNAH11-related disorder, DNAH11-related disorder |
| RS2535464638 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2535465944 |
EGFR
|
Health Risk |
Pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS2535467029 |
EGFR
|
Health Risk |
Pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS2535467680 |
SLC26A3
|
Health Risk |
Likely pathogenic |
— |
| RS2535468195 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS2535468277 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS2535468435 |
SLC26A3
|
Health Risk |
Likely pathogenic |
— |
| RS2535470241 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2535470506 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2535470681 |
DNAH11
|
Health Risk |
Likely pathogenic |
DNAH11-related disorder, DNAH11-related disorder |
| RS2535471250 |
SLC26A3
|
Health Risk |
Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS2535471415 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS2535472743 |
DDC
|
Health Risk |
Pathogenic |
Deficiency of aromatic-L-amino-acid decarboxylase, Deficiency of aromatic-L-amino-acid decarboxylase |
| RS2535474589 |
SLC26A3
|
Health Risk |
Likely pathogenic |
— |
| RS2535474668 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS2535477061 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS2535478074 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS2535478160 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS2535478180 |
SLC26A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS2535480477 |
LAMB1
|
Health Risk |
Pathogenic |
Cobblestone lissencephaly without muscular or ocular involvement, Cobblestone lissencephaly without muscular or ocular involvement |
| RS2535480497 |
LAMB1
|
Health Risk |
Pathogenic |
— |
| RS2535485381 |
LAMB1
|
Health Risk |
Pathogenic |
— |
| RS2535492454 |
MYO6
|
Health Risk |
Pathogenic |
— |
| RS2535492696 |
LAMB1
|
Health Risk |
Likely pathogenic |
Cobblestone lissencephaly without muscular or ocular involvement, Cobblestone lissencephaly without muscular or ocular involvement |
| RS2535494860 |
MYO6
|
Health Risk |
Likely pathogenic |
— |
| RS2535495055 |
MYO6
|
Health Risk |
Pathogenic |
— |
| RS2535499036 |
EGFR
|
Health Risk |
Likely pathogenic |
Lung adenocarcinoma, Lung adenocarcinoma |
| RS2535501445 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2535503276 |
COL11A2
|
Health Risk |
Pathogenic |
— |
| RS2535505726 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2535505828 |
COL11A2
|
Health Risk |
Pathogenic |
— |
| RS2535506167 |
DNAH11
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2535507289 |
EGFR
|
Health Risk |
Pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS2535507304 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2535508674 |
DST
|
Health Risk |
Pathogenic |
Hereditary sensory and autonomic neuropathy type 6, Epidermolysis bullosa simplex 3 |
| RS2535508959 |
PCLO
|
Health Risk |
Likely pathogenic |
— |
| RS2535510209 |
MYO6
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 37, Autosomal recessive nonsyndromic hearing loss 37 |
| RS2535514417 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2535516075 |
KRIT1
|
Health Risk |
Likely pathogenic |
— |
| RS2535517960 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2535518473 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2535518733 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2535518758 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |